JG ROSER IVS: Financial statements 2019
CVR: 37689963
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
JG ROSER IVS (CVR 37689963) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 329,249 and a net result of DKK 20,560 compared with DKK 11,435 the year before. That is an increase of 2,779.3% compared with the year before. Equity in the 2019 report amounted to DKK 51,908. The solvency ratio was 30.6%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 329,249
- Profit/Loss
- DKK 20,560
- Equity
- DKK 51,908
- Total Assets
- DKK 169,365
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 329K | 21K | 52K | 3 |
| 2018 | - | 11K | 11K | 31K | - |
| 2017 | - | -20K | -20K | 11K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
JG ROSER IVS has published its annual report for 2018. Gross profit came to DKK 11,435, and the net result was DKK 11,435.
As of February 27, 2019, Sadek Hamed Alwan Najem is registered as adm. dir. of JG ROSER IVS.
As of February 27, 2019, Sadek Hamed Alwan Najem is registered as chairman of JG ROSER IVS.
As of February 27, 2019, Jaffar Hamed Alwan Najem has stepped down as adm. dir. of JG ROSER IVS.
About JG ROSER IVS
JG ROSER IVS was a Danish company of the type Iværksætterselskab based in København N, founded in 2016. The company has been dissolved on 17 November 2021. The company was registered under the industry Blomsterforretninger. The company was previously named Bella Rose IVS. The company has 4 employees (2021). In 2019, the company reported a gross profit of DKK 329,249 and a net result of DKK 20,560 compared with DKK 11,435 the year before. Equity in the 2019 report amounted to DKK 51,908.